Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Avotaciclib (BEY1107) is a potent and orally active cyclin dependent kinase 1 (CDK1) inhibitor.Avotaciclib can be used to study locally advanced or metastatic pancreatic cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 119.00 | |
5 mg | In stock | $ 287.00 | |
10 mg | In stock | $ 456.00 | |
25 mg | In stock | $ 749.00 | |
50 mg | In stock | $ 1,060.00 | |
100 mg | In stock | $ 1,420.00 | |
500 mg | In stock | $ 2,850.00 |
Description | Avotaciclib (BEY1107) is a potent and orally active cyclin dependent kinase 1 (CDK1) inhibitor.Avotaciclib can be used to study locally advanced or metastatic pancreatic cancer. |
Synonyms | BEY1107, Avotaciclib |
Molecular Weight | 281.27 |
Formula | C13H11N7O |
CAS No. | 1983983-41-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (177.77 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Avotaciclib 1983983-41-0 Cell Cycle/Checkpoint CDK BEY1107 BEY-1107 BEY 1107 inhibitor inhibit